Envista Holdings Sets Second Quarter 2026 Earnings Date

Investors and stakeholders can access the live webcast through the company’s investor relations portal at www.envistaco.com, where accompanying presentation slides will be available for review prior to the call. Those preferring to participate via telephone may dial 1-800-836-8184 within the United States or +1 646-357-8785 for international access using Conference ID #73468. A recording of the session will remain accessible on the company website for one year following the event.

Envista operates a broad portfolio of more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The upcoming report serves as a benchmark for the company’s ongoing strategy in the global dental technology market, where it provides consumables, imaging systems, and digital orthodontics solutions. Jim Gustafson, Vice President of Investor Relations, serves as the primary contact for inquiries regarding the financial disclosure.